Molecular Hematopathology : An Integrated Case-Based Approach

個数:

Molecular Hematopathology : An Integrated Case-Based Approach

  • 在庫がございません。海外の書籍取次会社を通じて出版社等からお取り寄せいたします。
    通常6~9週間ほどで発送の見込みですが、商品によってはさらに時間がかかることもございます。
    重要ご説明事項
    1. 納期遅延や、ご入手不能となる場合がございます。
    2. 複数冊ご注文の場合は、ご注文数量が揃ってからまとめて発送いたします。
    3. 美品のご指定は承りかねます。

    ●3Dセキュア導入とクレジットカードによるお支払いについて
  • 【入荷遅延について】
    世界情勢の影響により、海外からお取り寄せとなる洋書・洋古書の入荷が、表示している標準的な納期よりも遅延する場合がございます。
    おそれいりますが、あらかじめご了承くださいますようお願い申し上げます。
  • ◆画像の表紙や帯等は実物とは異なる場合があります。
  • ◆ウェブストアでの洋書販売価格は、弊社店舗等での販売価格とは異なります。
    また、洋書販売価格は、ご注文確定時点での日本円価格となります。
    ご注文確定後に、同じ洋書の販売価格が変動しても、それは反映されません。
  • 製本 Hardcover:ハードカバー版/ページ数 326 p.
  • 言語 ENG
  • 商品コード 9780891896814

Full Description

Molecular Hematopathology: An Integrated Case-Based Approach, provides readers an integrated case-informed learning experience of Molecular Hematopathology focused on best-practice neoplastic hematopoietic disorders and related conditions. Through reviews of diagnostic approaches in which a combination of morphologic analysis, flow cytometry, and genetic testing (cytogenetics, FISH, PCR, and/or NGS) are used to best advantage, readers should significantly expand their understanding.

The text is not simply a catalog of every hematologic neoplasm having a defined cytogenetic or molecular abnormality, but rather a study of cases whose evaluations illustrate how specific chromosomal and molecular findings are used for diagnosis, prognosis, and for consideration for targeted therapy. Most of the individual chapters include summary tables that compare the described malignancy with similar entities, so that a very broad set of specific hematologic is considered throughout the text.

Two sets of quiz questions are also provided for aiding in self-study. The Appendices include a concise overview of cytogenetic and molecular techniques, including a complete guide to reading next generation sequencing (NGS) data. Standard nomenclature (2017 WHO Classification compliant) is used throughout.

Hematopathology has undergone several revolutionary periods, including the development of a classification system defining distinct, "real" entities (later evolved to the current WHO classification of hematologic neoplasms), advances in sophisticated immunophenotyping such as flow cytometry, and most recently, an explosion in molecular/genetic testing that greatly expands how we understand the pathophysiology of hematologic disease.

The extent, applications, and ramifications of the genomic revolution are still being developed and explored. This book demonstrates how novel advances in molecular and cellular biology translate to modern pathology practice.

最近チェックした商品